Investment News
🇪🇺 EMAEMA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–6 of 6 articles
ESMO 2025: Key Advances in Non-Muscle-Invasive Bladder Cancer Shape Future Oncology Strategies
Camizestrant Recommended for Approval in the EU for Advanced ER-Positive Breast Cancer
ESMO Breast Cancer Congress 2026: Key Insights for Investors
Swiss Biotech Day: Key Innovations and Partnerships Emerge
Swiss Biotech Day: Key Takeaways and Highlights
Drug Development Services Market Surges to $31.5 Billion in 2026, Driven by Pharmaceutical R&D Investments